Traders floated scenarios ranging from a $20 billion buyout to a potential partnership with UnitedHealth, reviving Viking’s ...
Shares of biopharma company Viking Therapeutics ($VKTX) rose as high as 5% during the first hour of trading on Monday. The ...
Viking Therapeutics shares surged to their highest level in nearly three months yesterday, propelled by intense market speculation about a potential acquisit ...
Major U.S. indices closed mixed on Tuesday, with the Dow Jones Industrial Average climbing 1.2% to 47,927.96 and the S&P 500 ...
After a thorough review of the options trading surrounding Viking Therapeutics, we move to examine the company in more detail. This includes an assessment of its current market status and performance.